What health insurance, trauma cover and the public system each pay for cancer in NZ in 2026 — surgery, drugs, the non-Pharmac gap and lost income mapped out across the whole journey.
Cancer is the most common serious illness New Zealanders face. It is also the one where the question "am I covered?" has the most complicated answer, because three very different things — the public health system, health insurance and trauma cover — each pay for a different part of the journey, and none of them pays for all of it. This article maps out who pays for what, from the first scan through to lost income, so the gaps are easier to see before you have to rely on any of it.
It is general information, not advice about your situation, but it should help you ask the right questions.
TL;DR: No single cover handles cancer end to end. The public system funds most diagnosis, surgery and Pharmac-funded treatment. Health insurance speeds up access and pays for non-Pharmac drugs up to a cap. Trauma cover pays a lump sum on diagnosis you can use for anything — including the income you lose. About 25,000 New Zealanders are diagnosed each year 2, and the three covers work best together.
How big is the cancer risk in New Zealand?
Cancer is the leading cause of death and health loss in New Zealand, accounting for roughly one in three of all deaths 1. About 25,000 people are diagnosed each year, and around 10,600 die from cancer annually 23. (Te Aho o Te Kahu's later State of Cancer in New Zealand 2025 report, published in December 2025, revised the annual diagnosis figure to over 30,000 — so treat 25,000 as the position at this article's date.)
Those numbers are not meant to alarm. The point is simpler: cancer is common enough that "what would actually be covered" is a fair question for most households to work through calmly, rather than a remote worst case.
What does the public system cover for cancer in NZ?
For most New Zealanders, the public system does the heavy lifting. Vote Health was funded at a record $16.68 billion in Budget 2024, which gives a sense of the scale of public spending behind it 10. Through Health New Zealand, the public system generally covers:
- diagnosis — GP referrals, scans, biopsies and specialist assessment;
- surgery to remove cancer;
- chemotherapy and radiotherapy delivered in the public system; and
- medicines that Pharmac funds.
The two things people most often run into are timing and the funded-medicines list. Public treatment is prioritised clinically, so urgent cancer care is generally fast, but some scans, specialist appointments or less urgent procedures can involve a wait. How that plays out, and where private cover can shorten it, is covered in [the public surgery waitlist and private cover](public-surgery-waitlist-private-cover-nz).
The second issue is medicines. Pharmac works to a fixed budget and funds a defined list of treatments. Budget 2024 added $604 million over four years to fund or widen access to up to 26 cancer treatments and 28 other medicines, with Pharmac estimating around 175,000 people would benefit in the first year 4. By 31 December 2024, Pharmac had progressed proposals for 50 medicines and funded 36 of them, including 17 cancer medicines 5. That is real progress. Even so, a number of modern cancer drugs sit outside the funded list, which is where the gap below comes in.
What does health insurance pay for cancer treatment?
Health insurance is medical cover. It pays for treatment, not a cash lump sum, and it does two main things for cancer.
The first is faster access to private treatment — private specialist appointments, scans, surgery and oncology, subject to the policy terms. This can matter where a public wait would otherwise apply.
The second is non-Pharmac drug cover. Many health policies include, or let you add, cover for Medsafe-approved cancer medicines that Pharmac does not fund. This is the benefit that fills the unfunded-drug gap, and it is capped. The dollar limits vary widely between policies and upgrades — the detail is set out in [non-Pharmac cancer drug cover caps](non-pharmac-cancer-drug-health-cover-caps-nz). Insurers offering non-Pharmac cover include Southern Cross and nib, among others, and the caps and conditions differ by plan.
Two limits matter. Health insurance is medically underwritten, so pre-existing conditions can be excluded, and a cancer already present or suspected before you take out cover generally will not be covered. And whether any claim is paid depends on the terms, conditions, exclusions and your disclosure. This is a summary only — always read the policy wording or product disclosure statement.
What does trauma cover pay, and how is it different?
Trauma cover (also called critical illness or living assurance) is the odd one out, and the most flexible. It pays a lump sum of cash when you are diagnosed with a defined condition that meets the policy's definition — cancer is the most common trauma claim — regardless of what treatment you have or what it costs.
That difference matters. Health insurance reimburses treatment bills. Trauma cover hands you money you can use for anything: an unfunded drug, the mortgage, time off work, travel to treatment, childcare, or simply a buffer while the household adjusts.
The trade-offs are real and worth stating plainly. Trauma cover pays only if your diagnosis meets the policy's specific definition — some early-stage or low-grade cancers pay a partial benefit or none at all, and the wording varies between insurers such as Partners Life, AIA, Fidelity Life, Asteron Life and Chubb. Many policies have an initial stand-down period for cancer (commonly around three months) before cover applies, and pre-existing conditions can be excluded. Whether a claim is paid depends on the terms, conditions, exclusions, stand-down periods, underwriting and your disclosure.
For how trauma sits alongside health insurance and income protection, and which tends to come first, see [health vs trauma vs income protection](health-vs-trauma-vs-income-protection-which-first-nz).
Where does the non-Pharmac drug gap sit across all three?
The unfunded-drug gap is the single most misunderstood part of cancer cover, so it is worth pinning down.
If a cancer medicine is Medsafe-approved but not funded by Pharmac, the public system generally does not pay for it, and the cost falls to the patient. One widely reported example was a patient paying about $5,000 a month for an unfunded treatment, and a full course of an unfunded drug can exceed $100,000 6. From 1 July 2025, Pharmac introduced transitional access arrangements that let patients in private facilities access newly funded cancer medicines for up to 12 months from the date Pharmac starts funding them — useful, but specific to medicines that are becoming funded 7.
So the gap is covered, partly, by two different things:
- health insurance pays for non-Pharmac drugs up to its cap (read your number — it ranges widely); and
- trauma cover pays a lump sum you can put toward an unfunded drug with no cap on what you spend it on, but only if your diagnosis meets the definition.
Neither is a complete answer on its own. A capped health benefit can run out on a long course of an expensive drug; a trauma lump sum can fall short of a six-figure treatment bill if it was sized for income replacement. Used together, they cover more of the same gap from two directions.
Surgery, chemo, radiotherapy and drugs: who pays what?
The table below maps the main costs of a cancer journey against the three covers. It is illustrative and general — what any specific policy pays depends on its wording, and what the public system funds can change.
Figure: Who pays what across the cancer journey
| Cost on the journey | Public system | Health insurance | Trauma cover |
|---|---|---|---|
| Diagnosis, scans, specialist | Yes, may involve a wait | Yes, faster private access (subject to terms) | Pays a lump sum once a covered diagnosis is confirmed |
| Surgery | Yes | Yes, private surgery (subject to terms) | Lump sum — use however you choose |
| Chemotherapy / radiotherapy | Yes, where publicly delivered | Yes, private (subject to terms) | Lump sum — use however you choose |
| Non-Pharmac (unfunded) drugs | Generally no 6 | Up to the policy cap 6 | Lump sum, no restriction on use (if definition met) |
| Income lost while off work | No (not a health cost) | No (pays treatment, not income) | Yes — lump sum can replace income |
| Travel and accommodation | Limited national travel assistance | Some plans include a benefit | Lump sum — use however you choose |
Source: Te Aho o Te Kahu, Pharmac and provider product disclosure statements, 2026; illustrative. Cover depends on the terms of the specific policy and your disclosure 267.
The pattern is clear. The public system and health insurance cover treatment. Only trauma cover responds to the costs that are not medical bills — chiefly income — which is the part people most often overlook.
Why is income loss during cancer the hidden cost?
Health insurance and the public system both pay providers, not you. So the moment cancer stops you working, neither one replaces the income that disappears — and treatment for cancer often means months away from full work, for you or a partner who steps back to help.
That gap is filled by either trauma cover (a lump sum) or income protection (a monthly benefit while you are unable to work). They do the job differently:
- Trauma cover pays once, on diagnosis, in a lump sum — useful for an immediate buffer, a drug, or paying down debt, but it does not keep paying month after month.
- Income protection pays a regular monthly amount through a long recovery, but it pays only while you meet the policy's disability test, not simply on diagnosis.
For working-age households, the income side is frequently the largest financial consequence of a cancer diagnosis, and the one the public system was never designed to address. ACC does not help here either — it covers injury, not illness.
How do you build cover that covers the whole journey?
There is no single product that does everything, so the practical task is matching covers to the parts of the journey you most want protected. These are things to weigh up, not a recommendation for your situation.
01. Start with the public system as your base. It funds most diagnosis, surgery and Pharmac-funded treatment. Decide what beyond that you want to protect.
02. Use health insurance for access and unfunded drugs. Check the non-Pharmac cap on your own plan, not the brochure headline.
03. Use trauma cover for the cash gaps. It is the only one of the three that pays for income, debt and the costs that are not treatment bills.
04. Consider income protection for a long recovery. A monthly benefit can carry the household where a lump sum runs out.
05. Check definitions, caps and stand-downs across providers. The wording differs between insurers, so compare on terms, not just price.
Cover can be compared across major NZ insurers and health funds — including Partners Life, AIA, Fidelity Life, Asteron Life and Chubb for trauma and income protection, and Southern Cross and nib for health insurance — on definitions and limits rather than headline price alone. For a broader look at how personal cover fits together, see our [guide to personal insurance](blog-post-personal-insurance).
Frequently asked questions
Does the public system cover cancer treatment in New Zealand? Largely, yes. The public system funds diagnosis, surgery, chemotherapy and radiotherapy, and medicines that Pharmac funds 45. The main gaps are timing on some non-urgent care, and cancer drugs that Pharmac does not fund, which generally fall to the patient 6.
What is the difference between health insurance and trauma cover for cancer? Health insurance reimburses treatment — private surgery, scans, oncology and non-Pharmac drugs up to a cap. Trauma cover pays a lump sum of cash on a covered diagnosis that you can use for anything, including income, debt or an unfunded drug. They cover different parts of the journey and many people hold both.
Will health insurance pay for non-Pharmac cancer drugs? Often, up to a cap, if your plan includes non-Pharmac drug cover. The dollar limits vary widely between policies and upgrades, and a full course of an unfunded drug can exceed $100,000 6. Read your own policy's number — see [non-Pharmac cancer drug cover caps](non-pharmac-cancer-drug-health-cover-caps-nz).
Does trauma cover pay out for any cancer? No. Trauma cover pays only if the diagnosis meets the policy's definition. Some early-stage or low-grade cancers pay a partial benefit or none, definitions differ between insurers, and there is usually an initial stand-down period for cancer. Whether a claim is paid depends on the terms and your disclosure.
What covers the income I lose during cancer treatment? Not the public system or health insurance — both pay for treatment, not income. Trauma cover (a lump sum on diagnosis) or income protection (a monthly benefit while you cannot work) are the covers designed for lost income. They work differently, and some households hold both — see [health vs trauma vs income protection](health-vs-trauma-vs-income-protection-which-first-nz).
Do I need all three types of cover? Not necessarily. Each covers a different part of the journey, and the right mix depends on your situation, budget and existing cover. This is general information — personalised advice works through what fits you.
This article is general information only and is not personalised financial advice. It does not take into account your particular financial situation, goals or needs. Before acting, consider whether it's right for you and seek advice tailored to your circumstances. Craig Smith Business Services Ltd (FSP712931), trading as Smiths Financial, holds a Class 2 licence issued by the Financial Markets Authority and is a member of the Financial Dispute Resolution Service (FDRS). KiwiSaver and insurance figures are set by Government and providers and can change. Whether an insurance claim is paid depends on the policy terms, conditions, exclusions, stand-down periods, underwriting and your disclosure; this is a summary only — always read the policy wording or product disclosure statement. Written by Henry Smith, Financial Adviser; reviewed by Craig Smith, Principal Adviser. Last reviewed 3 July 2025.
Sources
- 1.Te Aho o Te Kahu (Cancer Control Agency) — cancer is the leading cause of death and health loss in NZ (roughly one in three deaths), as at 3 July 2025.
- 2.Te Aho o Te Kahu (Cancer Control Agency) — Cancer Prevention Report (~25,000 diagnoses per year; revised to 30,000+ in the December 2025 State of Cancer report), as at 3 July 2025.
- 3.Te Aho o Te Kahu (Cancer Control Agency) — Cancer Prevention Report (~10,600 cancer deaths per year), as at 3 July 2025.
- 4.New Zealand Government (Beehive) — Transformative investment in cancer treatments and more new medicines ($604 million over four years; up to 26 cancer and 28 other treatments; ~175,000 people in the first year), announced 24 June 2024, as at 3 July 2025.
- 5.Pharmac — Year in Review, Budget increase for more medicines (36 of 50 medicines funded, including 17 cancer medicines), as at 31 December 2024.
- 6.The Spinoff / Newshub — reporting on unfunded cancer drugs (~$5,000 a month example; courses can exceed $100,000), June 2024, representative as at 3 July 2025.
- 7.Ministry of Health — Cabinet material, Enabling Transitional Access to Newly Funded Cancer Medicines for Patients in Private Facilities (effective 1 July 2025; up to 12 months transitional access).
- 8.New Zealand Government (Beehive) — Vote Health funded at a record $16.68 billion, Budget 2024, as at 3 July 2025.
Next step
Want to talk through what this means for your own cover or KiwiSaver setup? Book a 30-minute review with one of our advisers, no obligation, no sales pitch.
Book a free review
